Daniel R. Boué

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas

Ana Guerreiro Stücklin, Scott Ryall, Kohei Fukuoka et al. · Nature Communications · 2019 · 373 citations · Full text

Medicine, Cancer Biology, Oncology +15

Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors

Amanda M. Haidet, Liza Rizo, Chalonda R. Handy et al. · Proceedings of the National Academy of Sciences · 2008 · 261 citations · Full text

Medicine, Molecular Medicine, Pharmacotherapy +17

P-selectin-targeted nanocarriers induce active crossing of the blood–brain barrier via caveolin-1-dependent transcytosis

Daniel Tylawsky, Hiroto Kiguchi, Jake Vaynshteyn et al. · Nature Materials · 2023 · 205 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Antibody affinity may influence antigenic modulation of the common acute lymphoblastic leukemia antigen <i>in vitro</i>.

Tucker W. LeBien, Daniel R. Boué, J Bradley et al. · The Journal of Immunology · 1982 · 142 citations

Pharmacy, Immunology, Oncology +16

Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition

Liana Nobre, Michal Zápotocký, Vijay Ramaswamy et al. · JCO Precision Oncology · 2020 · 142 citations · Full text

Medicine, Oncology, Pediatrics +15